Abstract
Watch the video or read the poster to learn:  Why downstream processing remains one of the main bottlenecks in adenoviral vector manufacturing How an adenoviral vector purification platform using CIMmultus™ QA as the key purification step, secures a fast and robust process with better purity CIMmultus™QA offers high capacity and high yields of adenovirus, results in cost reduction and overcomes raw material supply bottlenecks Hana Jug is a Project Manager in process development for viral vectors and vaccines at BIA Separations, a Sartorius company. Hana has outstanding experience in downstream purification and analytics of demanding biologics. She has successfully managed several projects for clients in clinical phases, mainly in the field of gene therapy using adeno-associated virus, and vaccines using the adenovirus platform. She holds a BS in Biology from the University of Ljubljana, Slovenia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
